Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies

Takuya Tada, Hao Zhou, Belinda M. Dcosta, +6

EBioMedicine

Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies

Takuya Tada, Belinda M. Dcosta, Marie Samanovic-Golden, +4

Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants

Takuya Tada, Hao Zhou, Marie I. Samanovic, +4

Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies

Hao Zhou, Belinda M. Dcosta, Nathaniel R. Landau, +1

Viruses

VaccinationVaccine DevelopmentTherapeutic Monoclonal AntibodiesVaccine TargetImmunology +10

An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2

Takuya Tada, Fan Chen, Jennifer Chen, +7

Cell Reports

VaccinationVirus StructurePotent InhibitorVaccine TargetAce2 Microbody +13

Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies

Takuya Tada, Belinda M. Dcosta, Hao Zhou, +3

Viral EvolutionSpike ProteinMink Cluster 5MedicineVaccine Target +10

Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes

Takuya Tada, Belinda M. Dcosta, Marie I. Samanovic, +7

mBio

The Spike Proteins of SARS-CoV-2 B.1.617 and B.1.618 Variants Identified in India Provide Partial Resistance to Vaccine-elicited and Therapeutic Monoclonal Antibodies

Takuya Tada, Hao Zhou, Belinda M. Dcosta, +3

ImmunologyImmunodominanceViral Structural ProteinBroad-spectrum VaccinesCovid-19 +16

B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies

Hao Zhou, Belinda M. Dcosta, Marie I. Samanovic, +3

mBio

SARS-CoV-2 Lambda Variant Remains Susceptible to Neutralization by mRNA Vaccine-elicited Antibodies and Convalescent Serum

Takuya Tada, Hao Zhou, Belinda M. Dcosta, +3

VaccinationLambda SpikeVaccine DevelopmentMedicineVaccine Target +13